Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Aerpio and Quantum Leap Announce First Patients Dosed with Razuprotafib in the I-SPY COVID Trial to Treat ARDS in Critically-ill COVID-19 Patients

prnewswireSeptember 03, 2020

Tag: Aerpio , Quantum Leap , Razuprotafib , I-SPY COVID Trial

PharmaSources Customer Service